Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5806 USD | -7.84% | -7.25% | -53.55% |
Valuation
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 35.21 | 21.75 | 73.14 | 44.9 | 44.98 | 23.05 |
Enterprise Value (EV) 1 | 34.01 | 21.06 | 66.29 | 42.32 | 40.44 | 14.41 |
P/E ratio | -23.8 x | -8.65 x | -28.1 x | -6.73 x | -9.72 x | -2.72 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 6.33 x | 4.18 x | 10.9 x | 6.24 x | 2.38 x | 4.32 x |
EV / Revenue | 6.11 x | 4.05 x | 9.9 x | 5.88 x | 2.14 x | 2.7 x |
EV / EBITDA | -26.3 x | -9.36 x | -29.2 x | -6.63 x | -9.64 x | -2.1 x |
EV / FCF | -43.7 x | -13.8 x | -19.9 x | -15 x | 37.8 x | -5.84 x |
FCF Yield | -2.29% | -7.25% | -5.04% | -6.66% | 2.64% | -17.1% |
Price to Book | 8.36 x | 5.47 x | 5.35 x | 4.87 x | 5.41 x | 1.97 x |
Nbr of stocks (in thousands) | 8,652 | 9,667 | 11,305 | 12,302 | 12,852 | 16,822 |
Reference price 2 | 4.070 | 2.250 | 6.470 | 3.650 | 3.500 | 1.370 |
Announcement Date | 8/29/18 | 8/29/19 | 8/31/20 | 8/27/21 | 8/29/22 | 8/25/23 |
Income Statement Evolution (Annual data)
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 5.564 | 5.201 | 6.693 | 7.199 | 18.87 | 5.339 |
EBITDA 1 | -1.295 | -2.25 | -2.274 | -6.384 | -4.195 | -6.849 |
EBIT 1 | -1.482 | -2.413 | -2.403 | -6.522 | -4.534 | -6.933 |
Operating Margin | -26.63% | -46.39% | -35.9% | -90.6% | -24.03% | -129.86% |
Earnings before Tax (EBT) 1 | -1.434 | -2.369 | -2.332 | -6.456 | -4.507 | -7.089 |
Net income 1 | -1.466 | -2.393 | -2.339 | -6.469 | -4.531 | -7.14 |
Net margin | -26.34% | -46.01% | -34.95% | -89.86% | -24.01% | -133.73% |
EPS 2 | -0.1710 | -0.2600 | -0.2301 | -0.5423 | -0.3600 | -0.5044 |
Free Cash Flow 1 | -0.7777 | -1.526 | -3.338 | -2.818 | 1.07 | -2.465 |
FCF margin | -13.98% | -29.35% | -49.88% | -39.14% | 5.67% | -46.17% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/29/18 | 8/29/19 | 8/31/20 | 8/27/21 | 8/29/22 | 8/25/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: May | 2022 Q2 |
---|---|
Net sales 1 | 4.647 |
EBITDA | - |
EBIT 1 | -1.13 |
Operating Margin | -24.31% |
Earnings before Tax (EBT) | - |
Net income 1 | -1.125 |
Net margin | -24.22% |
EPS 2 | -0.0900 |
Dividend per Share | - |
Announcement Date | 1/12/22 |
Balance Sheet Analysis
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 1.2 | 0.69 | 6.86 | 2.58 | 4.54 | 8.64 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.78 | -1.53 | -3.34 | -2.82 | 1.07 | -2.47 |
ROE (net income / shareholders' equity) | -33.3% | -57.6% | -25.7% | -55.2% | -51.6% | -71.2% |
ROA (Net income/ Total Assets) | -18.1% | -28.8% | -13.3% | -28% | -24.4% | -33.6% |
Assets 1 | 8.104 | 8.306 | 17.53 | 23.07 | 18.54 | 21.28 |
Book Value Per Share 2 | 0.4900 | 0.4100 | 1.210 | 0.7500 | 0.6500 | 0.7000 |
Cash Flow per Share 2 | 0.1400 | 0.0700 | 0.7400 | 0.3400 | 0.4600 | 0.5800 |
Capex 1 | 0.13 | 0.1 | 0.03 | 0.14 | 0.06 | 0.06 |
Capex / Sales | 2.34% | 1.94% | 0.5% | 1.89% | 0.3% | 1.2% |
Announcement Date | 8/29/18 | 8/29/19 | 8/31/20 | 8/27/21 | 8/29/22 | 8/25/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.55% | 9.77M | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- BMRA Stock
- Financials Biomerica, Inc.